Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population
- PMID: 23573237
- PMCID: PMC3616004
- DOI: 10.1371/journal.pone.0060142
Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population
Abstract
Objective: Colorectal cancer (CRC) development involves underlying modifications at genetic/epigenetic level. This study evaluated the role of Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation together/independently in sporadic CRC in Indian population and correlation with clinicopathological variables of the disease.
Methods: One hundred and twenty four consecutive surgically resected tissues (62 tumor and equal number of normal adjacent controls) of primary sporadic CRC were included and patient details including demographic characteristics, lifestyle/food or drinking habits, clinical and histopathological profiles were recorded. Polymerase chain reaction - Restriction fragment length polymorphism and direct sequencing for Kras gene mutation and Methylation Specific-PCR for RASSF1A, FHIT and MGMT genes was performed.
Results: Kras gene mutation at codon 12 & 13 and methylated RASSF1A, FHIT and MGMT gene was observed in 47%, 19%, 47%, 37% and 47% cases, respectively. Alcohol intake and smoking were significantly associated with presence of Kras mutation (codon 12) and MGMT methylation (p-value <0.049). Tumor stage and metastasis correlated with presence of mutant Kras codon 12 (p-values 0.018, 0.044) and methylated RASSF1A (p-values 0.034, 0.044), FHIT (p-values 0.001, 0.047) and MGMT (p-values 0.018, 0.044) genes. Combinatorial effect of gene mutation/methylation was also observed (p-value <0.025). Overall, tumor stage 3, moderately differentiated tumors, presence of lymphatic invasion and absence of metastasis was more frequently observed in tumors with mutated Kras and/or methylated RASSF1A, FHIT and MGMT genes.
Conclusion: Synergistic interrelationship between these genes in sporadic CRC may be used as diagnostic/prognostic markers in assessing the overall pathological status of CRC.
Conflict of interest statement
Similar articles
-
Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.Cancer Genet. 2020 Feb;241:42-50. doi: 10.1016/j.cancergen.2019.10.002. Epub 2019 Oct 13. Cancer Genet. 2020. PMID: 31653608
-
MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.Ann Oncol. 2009 Jul;20(7):1216-22. doi: 10.1093/annonc/mdn782. Epub 2009 Jan 22. Ann Oncol. 2009. PMID: 19164452
-
MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa.Mod Pathol. 2009 Dec;22(12):1588-99. doi: 10.1038/modpathol.2009.130. Epub 2009 Sep 4. Mod Pathol. 2009. PMID: 19734844
-
Prognostic value of MGMT methylation in colorectal cancer: a meta-analysis and literature review.Tumour Biol. 2015 Mar;36(3):1595-601. doi: 10.1007/s13277-014-2752-9. Epub 2015 Jan 17. Tumour Biol. 2015. PMID: 25596081 Review.
-
Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2017 Apr;96(17):e6708. doi: 10.1097/MD.0000000000006708. Medicine (Baltimore). 2017. PMID: 28445279 Free PMC article. Review.
Cited by
-
Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutations.Int J Environ Res Public Health. 2014 Aug 25;11(9):8645-60. doi: 10.3390/ijerph110908645. Int J Environ Res Public Health. 2014. PMID: 25158139 Free PMC article.
-
A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.Tumour Biol. 2013 Oct;34(5):3159-63. doi: 10.1007/s13277-013-0885-x. Epub 2013 Jun 2. Tumour Biol. 2013. PMID: 23729275
-
FHIT down-regulation was inversely linked to aggressive behaviors and adverse prognosis of gastric cancer: a meta- and bioinformatics analysis.Oncotarget. 2017 Nov 3;8(64):108261-108273. doi: 10.18632/oncotarget.22369. eCollection 2017 Dec 8. Oncotarget. 2017. PMID: 29296239 Free PMC article.
-
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma.BMC Cancer. 2014 Jul 11;14:511. doi: 10.1186/1471-2407-14-511. BMC Cancer. 2014. PMID: 25015560 Free PMC article.
-
Molecular basis of epigenetic regulation in cancer diagnosis and treatment.Front Genet. 2022 Aug 24;13:885635. doi: 10.3389/fgene.2022.885635. eCollection 2022. Front Genet. 2022. PMID: 36092905 Free PMC article. Review.
References
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893–2917. - PubMed
-
- Notani PN (2001) Global variation in cancer incidence and mortality. Current Science 81: 465–474.
-
- Jemal A, Bray F (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90. - PubMed
-
- Brink M, Weijenberg MP, De Goeij AF, Schouten LJ, Koedijk FD, et al. (2004) Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 25: 1619–1628. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous